| IMMUTEP LTD |
| Australien |
| Gesundheit |
| AU000000IMM6 / A2H81H |
| YP1B (Frankfurt) |
| FRA:YP1B, ETR:YP1B, YP1B:GR |
| - |
| https://www.immutep.com/ |
|
Immutep Limited is a late-stage biotechnology comp..
>Volltext.. |
| 350.93 Mio. EUR |
| 279.59 Mio. EUR |
| - |
| -37.81 Mio. EUR |
| -34.2 Mio. EUR |
| -0.02 EUR |
| 0.9 Mio. EUR |
| 37.52 Mio. EUR |
| -34.54 Mio. EUR |
| 10.16 |
| - |
| -29% |
| - |
| - |
| - |
| - |
| IMMUTEP |
| 04.02.26 |
|